BFHIV Stock Price, News & Analysis
Company Description
BFHIV (BFHIV) is a publicly traded company.
On a trailing twelve-month basis, BFHIV reported revenue of $3.8B with net income of $518.0M and diluted earnings per share of $10.89. The company operates at a net profit margin of 13.5%.
This page provides a comprehensive overview of BFHIV stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
BFHIV Rankings
Latest News
SEC Filings
BFHIV has filed 10 recent SEC filings, including 4 Form 8-K, 2 Form 4, 2 Form 144, 2 Form 424B5. The most recent filing was submitted on May 22, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BFHIV SEC filings →
Financial Highlights
BFHIV generated $3.8B in revenue over the trailing twelve months, and net income was $518.0M, reflecting a 13.5% net profit margin. Diluted earnings per share stood at $10.89. The company generated $2.1B in operating cash flow.